California's $30 Million Bet On a Cancer Treatment: New Company Formed to Bring the Therapy to Market
Highlights
Stanford, Weissman involved
Good news for CIRM
Google hooked in
A new stem cell company that targets cancer by unleashing an “eat me” trigger has emerged from a $30 million investment by the state of California.
Creation of the Palo Alto firm, which is called Forty Seven, Inc., was announced this week by its backers and its key researcher, Irv Wei…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.